TrialCritical care (London, England)2020

High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial.

Andrea Cortegiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.